A Study to Explore Efficacy and Safety of ASP015K in Subjects With Moderate to Severe Psoriasis
Clinical trial NCT01096862 · COMPLETED
Trial details
- NCT number
- NCT01096862
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-23
- Primary completion
- 2011-07-27
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.